Radcliffe, IA, United States of America

Kelly Burkhart

This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, United States of America, as Represented by the Secretary of Agriculture, Other. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kelly Burkhart. Retrieved from https://idiyas.com/inventor/kelly-burkhart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 60.0


 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2003-2014

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kelly Burkhart: Innovator in Veterinary Vaccines

Introduction

Kelly Burkhart is a notable inventor based in Radcliffe, IA (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for porcine reproductive and respiratory syndrome (PRRS). With a total of 5 patents, Burkhart's work has had a profound impact on animal health.

Latest Patents

One of Burkhart's latest patents focuses on a porcine reproductive and respiratory syndrome vaccine based on isolate JA-142. This invention provides substantially avirulent forms of atypical PRRS virus and corresponding vaccines that result from cell culture passaging of virulent forms of PRRS. The resultant avirulent atypical PRRS virus is useful as a vaccine, as it elicits a PRRS specific antibody response when host animals are inoculated. This response confers effective immunity against both previously known strains of PRRS virus and newly isolated atypical PRRS virus strains. The preferred passaging technique ensures that the virus remains in a logarithmic growth phase throughout the process, minimizing the time required to achieve attenuation. Additionally, the invention includes diagnostic testing methods that can differentiate between animals infected with field strains and attenuated strains of PRRSV.

Career Highlights

Throughout his career, Kelly Burkhart has worked with prominent companies in the veterinary field, including Boehringer Ingelheim Vetmedica GmbH. His expertise and innovative approach have positioned him as a leader in the development of effective vaccines for swine health.

Collaborations

Burkhart has collaborated with esteemed colleagues such as William L. Mengeling and Ann C. Vorwald, who have contributed to his research and development efforts in veterinary medicine.

Conclusion

Kelly Burkhart's contributions to the field of veterinary vaccines, particularly in combating PRRS, highlight his innovative spirit and dedication to animal health. His work continues to influence the industry and improve the well-being of livestock.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…